AUBRY VAN NOY: Open Payments
NPI 1750942991 · PROSPER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 118 payments from 17 companies in 2025. Trend: 2023 $2,285 · 2024 $1,722 · 2025 $2,156
Food & beverage: $2,056Education: $100
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $449 |
| Amgen Inc. | 8 | $210 |
| Galderma Laboratories, L.P. | 14 | $196 |
| Janssen Biotech, Inc. | 5 | $192 |
| Lilly USA, LLC | 8 | $177 |
| Novartis Pharmaceuticals Corporation | 7 | $171 |
| MAYNE PHARMA COMMERCIAL LLC | 21 | $168 |
| Arcutis Biotherapeutics, Inc. | 10 | $147 |
| GENZYME CORPORATION | 5 | $144 |
| LEO Pharma Inc. | 5 | $110 |
Products named: DUPIXENT, Otezla, TREMFYA, NEMLUVIO, Zoryve, TALTZ, ADBRY, EBGLYSS.
Industry payments across TX — which companies pay providers there.
